Patents by Inventor Russell MADISON

Russell MADISON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240093304
    Abstract: The present disclosure provides COL5A2-ALK fusion nucleic acid molecules and polypeptides, and COL3A1-ALK fusion nucleic acid molecules and polypeptides, as well as methods, kits and reagents for detecting such fusion nucleic acid molecules and polypeptides. The disclosure also provides methods for evaluating, identifying, assessing, and/or treating an individual having a cancer.
    Type: Application
    Filed: December 29, 2021
    Publication date: March 21, 2024
    Applicant: Foundation Medicine, Inc.
    Inventors: Rachel ERBACH, Mark ROSENZWEIG, Megan FRIEDRICHSEN, Pierre VANDEN BORRE, Russell MADISON
  • Publication number: 20230140123
    Abstract: Described herein are methods, devices, and systems for identifying a subset of a plurality of features, using one or more feature importance metrics, for training and using a homologous repair deficiency (HRD) classification model. Further described are methods, devices, and systems for classifying a tumor of a cancer, such as pancreatic cancer, as likely HRD positive or likely HRD negative, and for calling the tumor as HRD positive or HRD negative.
    Type: Application
    Filed: August 30, 2022
    Publication date: May 4, 2023
    Applicant: Foundation Medicine, Inc.
    Inventors: Ethan SOKOL, Jay MOORE, Justin NEWBERG, Dexter JIN, Kuei-Ting CHEN, Russell MADISON
  • Patent number: D984580
    Type: Grant
    Filed: April 7, 2021
    Date of Patent: April 25, 2023
    Inventor: Brady Russell Madison